14 Best Biotech Penny Stocks to Buy Right Now

Page 9 of 13

5. MannKind Corporation (NASDAQ:MNKD)

Stock Price: $3.90

Number of Hedge Fund Holders: 29

MannKind Corporation (NASDAQ:MNKD) is one of the best biotech penny stocks to buy right now. Analyst Yun Zhong from Wedbush maintained a Buy rating on MannKind Corporation (NASDAQ:MNKD) on June 27, setting an $11.00 price target.

The analyst based the rating on MannKind Corporation’s (NASDAQ:MNKD) innovative inhaled insulin product, Afrezza, stating that it represents a considerably undervalued opportunity in the diabetes treatment market.

Clinical data from the Phase 3 INHALE-1 and INHALE-3 studies support Afrezza’s potential in both the adult and pediatric population. The data also highlights the product’s fit in the current treatment paradigm, positioning it as an ultra-rapid acting insulin option that may boost market adoption.

MannKind Corporation (NASDAQ:MNKD) is a biopharmaceutical company that develops and commercializes innovative therapeutic devices and products that address serious unmet medical needs for endocrine and orphan lung diseases.

The company’s pipeline and products include Afrezza, Pediatric Afrezza, V-Go, Tyvaso DPI, MNKD-101, MNKD-201, MNKD-301, and MNKD-501.

Page 9 of 13